Onatasertib (CC 223) CAS：1228013-30-6

Onatasertib,also known as CC-223,is an orally available inhibitor of the mammalian target of rapamycin(mTOR)with potential antineoplastic activity.mTOR kinase inhibitor CC-223 inhibits the activity of mTOR,which may result in the induction of tumor cell apoptosis and a decrease in tumor cell proliferation. mTOR,a serine/threonine kinase that is upregulated in a variety of tumors,plays an important role downstream in the PI3K/AKT/mTOR signaling pathway,which is frequently dysregulated in human cancers.

msds---Onatasertib (CC 223)